急性冠状动脉综合症

基质金属蛋白酶（Matrixmetalloproteinases，MMP）作为ECM的主要降解酶，在AS及急性冠状动脉综合症的过程中越来越受到人们的重视。

Matrix metalloproteinases ( MMP ) as main degradation enzyme of ECM is increasingly attached importance to in the course of atherosclerosis and acute coronary syndrome .

实际上慢性心绞痛和稳定型冠心病患者选择PCI治疗和急性冠状动脉综合症患者实施PCI在技术上是一样的。

PCI performed electively in patients with chronic angina and stable CAD is virtually identical technically to that performed in acute coronary syndrome ( ACS ) patients .

不同剂量普伐他汀对急性冠状动脉综合症血脂及vWF因子的影响

Effects of different administration of Pravastatin on blood fat and vWF factor of patients with acute coronary syndromes

结果急性冠状动脉综合症病人的D-二聚体水平较健康人明显升高。急性心肌梗死发病时间（＜6h）与D-二聚体水平无明显相关。

Results D-dimer was significantly higher in patients with acute ischemic event ( myocardial infarction and unstable angina ) than in nonischemic patients .

目的：总结急性冠状动脉综合症治疗进展。

Objective To summarize the treating progress of acute coronary artery syndromes .

急性冠状动脉综合症患者血脂联合检测及临床意义

Detection Lipid with Acute Coronary Syndrome and Its Clinic Application